MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs

Core Points - The MASS Coalition supports President Trump's Freeze Order, which halts the implementation of Medicare Local Coverage Determinations (LCDs) for skin substitute products until at least April 13, 2025 [1][2] - The Freeze Order is seen as a necessary action to prevent a healthcare crisis for diabetic patients who rely on skin substitutes for treatment [2] - The MASS Coalition consists of wound care companies dedicated to ensuring access to essential wound care products for Medicare beneficiaries [3] Company Overview - Celularity Inc. is a regenerative medicine company focused on developing advanced biomaterial products and placental-derived cell therapies targeting aging-related diseases, cancer, and immune disorders [4] - The company utilizes mesenchymal-like adherent stromal cells (MLASCs), CAR T-cells, and natural killer (NK) cells in its therapeutic programs [4] - Celularity aims to address significant unmet global needs for effective and affordable therapies by leveraging the unique biology of the placenta [4]